Date

Friday, 04 September 2015

Location

European Medicines Agency, Amsterdam, the Netherlands

Around 100 representatives from patient organisations, health-technology-assessment bodies, regulators, payers, academia and industry are expected to attend this kick-off meeting for a 30-month project called 'ADAPT SMART', which stands for accelerated development of appropriate patient therapies: a sustainable, multi-stakeholder approach from research to treatment outcomes. The project aims to establish a platform for coordinating activities related to 'Medicines Adaptive Pathways to Patients' and enable stakeholder dialogue in this field. It is implemented under an Innovative Medicines Initiative joint undertaking, a public-private partnership between the European Commission and the biopharmaceutical industry. Registration by invitation only.

Share this page